LIFEWARD LTD (LFWD) Fundamental Analysis & Valuation

NASDAQ:LFWD • IL0011331076

6.005 USD
+0.05 (+0.92%)
Last: Mar 6, 2026, 08:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This LFWD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to LFWD. LFWD was compared to 184 industry peers in the Health Care Equipment & Supplies industry. While LFWD seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, LFWD is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

0

1. LFWD Profitability Analysis

1.1 Basic Checks

  • In the past year LFWD has reported negative net income.
  • In the past year LFWD has reported a negative cash flow from operations.
  • LFWD had negative earnings in each of the past 5 years.
  • LFWD had a negative operating cash flow in each of the past 5 years.
LFWD Yearly Net Income VS EBIT VS OCF VS FCFLFWD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -127.62%, LFWD is doing worse than 84.78% of the companies in the same industry.
  • LFWD has a Return On Equity of -231.80%. This is in the lower half of the industry: LFWD underperforms 74.46% of its industry peers.
Industry RankSector Rank
ROA -127.62%
ROE -231.8%
ROIC N/A
ROA(3y)-52.11%
ROA(5y)-43.2%
ROE(3y)-76.61%
ROE(5y)-60.74%
ROIC(3y)N/A
ROIC(5y)N/A
LFWD Yearly ROA, ROE, ROICLFWD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -200 -400 -600 -800 -1K

1.3 Margins

  • Looking at the Gross Margin, with a value of 37.49%, LFWD is doing worse than 70.65% of the companies in the same industry.
  • LFWD's Gross Margin has declined in the last couple of years.
  • LFWD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 37.49%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.02%
GM growth 5Y-10.56%
LFWD Yearly Profit, Operating, Gross MarginsLFWD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. LFWD Health Analysis

2.1 Basic Checks

  • LFWD does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for LFWD has been increased compared to 1 year ago.
  • The number of shares outstanding for LFWD has been increased compared to 5 years ago.
  • There is no outstanding debt for LFWD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
LFWD Yearly Shares OutstandingLFWD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
LFWD Yearly Total Debt VS Total AssetsLFWD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • LFWD has an Altman-Z score of -11.54. This is a bad value and indicates that LFWD is not financially healthy and even has some risk of bankruptcy.
  • LFWD has a Altman-Z score of -11.54. This is in the lower half of the industry: LFWD underperforms 78.80% of its industry peers.
  • LFWD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -11.54
ROIC/WACCN/A
WACC8.58%
LFWD Yearly LT Debt VS Equity VS FCFLFWD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

2.3 Liquidity

  • A Current Ratio of 1.92 indicates that LFWD should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.92, LFWD is doing worse than 63.59% of the companies in the same industry.
  • LFWD has a Quick Ratio of 1.13. This is a normal value and indicates that LFWD is financially healthy and should not expect problems in meeting its short term obligations.
  • LFWD's Quick ratio of 1.13 is on the low side compared to the rest of the industry. LFWD is outperformed by 72.83% of its industry peers.
Industry RankSector Rank
Current Ratio 1.92
Quick Ratio 1.13
LFWD Yearly Current Assets VS Current LiabilitesLFWD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. LFWD Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 25.30% over the past year.
  • LFWD shows a decrease in Revenue. In the last year, the revenue decreased by -2.02%.
  • The Revenue has been growing by 39.41% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)25.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%42.86%
Revenue 1Y (TTM)-2.02%
Revenue growth 3Y62.63%
Revenue growth 5Y39.41%
Sales Q2Q%1.09%

3.2 Future

  • Based on estimates for the next years, LFWD will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.57% on average per year.
  • Based on estimates for the next years, LFWD will show a very strong growth in Revenue. The Revenue will grow by 40.19% on average per year.
EPS Next Y52.25%
EPS Next 2Y37.09%
EPS Next 3Y25.45%
EPS Next 5Y18.57%
Revenue Next Year-2.4%
Revenue Next 2Y29.25%
Revenue Next 3Y33.2%
Revenue Next 5Y40.19%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
LFWD Yearly Revenue VS EstimatesLFWD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M
LFWD Yearly EPS VS EstimatesLFWD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -100 -200 -300 -400

More info and screens

Find the best growth stocksShow best growing peers

1

4. LFWD Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for LFWD. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LFWD. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LFWD Price Earnings VS Forward Price EarningsLFWD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LFWD Per share dataLFWD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1

4.3 Compensation for Growth

  • A more expensive valuation may be justified as LFWD's earnings are expected to grow with 25.45% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.09%
EPS Next 3Y25.45%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. LFWD Dividend Analysis

5.1 Amount

  • No dividends for LFWD!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

LFWD Fundamentals: All Metrics, Ratios and Statistics

LIFEWARD LTD

NASDAQ:LFWD (3/6/2026, 8:00:02 PM)

6.005

+0.05 (+0.92%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-19
Earnings (Next)05-13
Inst Owners4.38%
Inst Owner ChangeN/A
Ins Owners1.73%
Ins Owner Change26.89%
Market Cap9.13M
Revenue(TTM)24.50M
Net Income(TTM)-29.57M
Analysts82.5
Price TargetN/A
Short Float %N/A
Short Ratio7.6
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-38.82%
Min EPS beat(2)-86.44%
Max EPS beat(2)8.8%
EPS beat(4)1
Avg EPS beat(4)-28.68%
Min EPS beat(4)-86.44%
Max EPS beat(4)8.8%
EPS beat(8)2
Avg EPS beat(8)-17.81%
EPS beat(12)3
Avg EPS beat(12)-15.18%
EPS beat(16)3
Avg EPS beat(16)-24.07%
Revenue beat(2)0
Avg Revenue beat(2)-9.96%
Min Revenue beat(2)-16.17%
Max Revenue beat(2)-3.76%
Revenue beat(4)0
Avg Revenue beat(4)-9.94%
Min Revenue beat(4)-16.17%
Max Revenue beat(4)-3.76%
Revenue beat(8)0
Avg Revenue beat(8)-10.39%
Revenue beat(12)2
Avg Revenue beat(12)-10%
Revenue beat(16)2
Avg Revenue beat(16)-18.6%
PT rev (1m)0%
PT rev (3m)31.82%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.84%
EPS NY rev (1m)0%
EPS NY rev (3m)15.92%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.82%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.43%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.48
P/FCF N/A
P/OCF N/A
P/B 8.61
P/tB 13.73
EV/EBITDA N/A
EPS(TTM)-1.86
EYN/A
EPS(NY)-0.27
Fwd EYN/A
FCF(TTM)-0.94
FCFYN/A
OCF(TTM)-0.94
OCFYN/A
SpS1.34
BVpS0.7
TBVpS0.44
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -127.62%
ROE -231.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 37.49%
FCFM N/A
ROA(3y)-52.11%
ROA(5y)-43.2%
ROE(3y)-76.61%
ROE(5y)-60.74%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.02%
GM growth 5Y-10.56%
F-Score4
Asset Turnover1.06
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.41%
Cap/Sales 0.02%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.92
Quick Ratio 1.13
Altman-Z -11.54
F-Score4
WACC8.58%
ROIC/WACCN/A
Cap/Depr(3y)5.59%
Cap/Depr(5y)12.01%
Cap/Sales(3y)0.35%
Cap/Sales(5y)0.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%42.86%
EPS Next Y52.25%
EPS Next 2Y37.09%
EPS Next 3Y25.45%
EPS Next 5Y18.57%
Revenue 1Y (TTM)-2.02%
Revenue growth 3Y62.63%
Revenue growth 5Y39.41%
Sales Q2Q%1.09%
Revenue Next Year-2.4%
Revenue Next 2Y29.25%
Revenue Next 3Y33.2%
Revenue Next 5Y40.19%
EBIT growth 1Y16.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y14.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y14.06%
OCF growth 3YN/A
OCF growth 5YN/A

LIFEWARD LTD / LFWD FAQ

Can you provide the ChartMill fundamental rating for LIFEWARD LTD?

ChartMill assigns a fundamental rating of 3 / 10 to LFWD.


Can you provide the valuation status for LIFEWARD LTD?

ChartMill assigns a valuation rating of 1 / 10 to LIFEWARD LTD (LFWD). This can be considered as Overvalued.


What is the profitability of LFWD stock?

LIFEWARD LTD (LFWD) has a profitability rating of 0 / 10.


How financially healthy is LIFEWARD LTD?

The financial health rating of LIFEWARD LTD (LFWD) is 5 / 10.


What is the expected EPS growth for LIFEWARD LTD (LFWD) stock?

The Earnings per Share (EPS) of LIFEWARD LTD (LFWD) is expected to grow by 52.25% in the next year.